CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-02 | Santos Esteban EVP, Operations | Grant or award · Nqso (Right to Buy) | +29,695 | 29,695 | ||
| 2022-05-02 | REESE DAVID M EVP, Research and Development | Grant or award | +3,897 | 51,652 | ||
| 2022-05-02 | REESE DAVID M EVP, Research and Development | Grant or award · Nqso (Right to Buy) | +31,817 | 31,817 | ||
| 2022-05-02 | Miller Derek SVP, Human Resources | Grant or award | +866 | 6,109 | ||
| 2022-05-02 | Miller Derek SVP, Human Resources | Grant or award · Nqso (Right to Buy) | +7,070 | 7,070 | ||
| 2022-05-02 | Louie Linda H. VP, Finance & CAO | Grant or award | +433 | 9,437 | ||
| 2022-05-02 | Louie Linda H. VP, Finance & CAO | Grant or award · Nqso (Right to Buy) | +3,535 | 3,535 | ||
| 2022-05-02 | Khosla Rachna SVP, Business Development | Grant or award | +606 | 7,434 | ||
| 2022-05-02 | Khosla Rachna SVP, Business Development | Grant or award · Nqso (Right to Buy) | +4,949 | 4,949 | ||
| 2022-05-02 | Grygiel Nancy A. SVP & CCO | Grant or award | +649 | 14,978 | ||
| 2022-05-02 | Grygiel Nancy A. SVP & CCO | Shares withheld for taxes | −57 | $230.92 | $13K | 14,921 |
| 2022-05-02 | Grygiel Nancy A. SVP & CCO | Grant or award · Nqso (Right to Buy) | +5,302 | 5,302 | ||
| 2022-05-02 | Griffith Peter H. EVP & CFO | Grant or award | +3,897 | 27,929 | ||
| 2022-05-02 | Griffith Peter H. EVP & CFO | Shares withheld for taxes · Nqso (Right to Buy) | −31,817 | 31,817 | ||
| 2022-05-02 | Graham Jonathan P EVP, Gen. Counsel & Secy. | Grant or award | +3,377 | 51,973 | ||
| 2022-05-02 | Graham Jonathan P EVP, Gen. Counsel & Secy. | Grant or award · Nqso (Right to Buy) | +27,574 | 27,574 | ||
| 2022-05-02 | Gordon Murdo EVP Global Commercial Ops | Grant or award | +4,330 | 49,195 | ||
| 2022-05-02 | Gordon Murdo EVP Global Commercial Ops | Grant or award · Nqso (Right to Buy) | +35,352 | 70,704 | ||
| 2022-05-02 | Bradway Robert A Chairman, CEO and President | Grant or award | +13,781 | 624,550 | ||
| 2022-05-02 | Bradway Robert A Chairman, CEO and President | Grant or award · Nqso (Right to Buy) | +112,508 | 112,508 |
Page 27 of 28 · 552 trades